 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Tuberculosis Clinical Diagnostics Research Consortium (TB CDRC) |
| Street 1: | Johns Hopkins University School of Medicine; Center for TB Research and Boston Medical Center/Boston University |
| Street 2: | |
| City: | Baltimore |
| Province: | MD |
| Post Code: | 21231 |
| Country: | United States of America |
| Phone: | 617-414-5277 |
| Organization Email: | david.hom@bmc.org |
| Web Site: | http://www.tbcdrc.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Technical agencies |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Academic / Research Institution |
| Organization Type - Secondary: | None |
| Organization Description: | |
| The Tuberculosis Clinical Diagnostics Research Consortium (TB CDRC) was established September 30, 2009 by the award of a contract to Johns Hopkins University from the Division of Microbiology and Infectious Diseases of the National Institute for Allergy and Infectious Diseases of the National Institutes of Health. The CDRC is an inter-disciplinary consortium of scientists, clinicians and other trained personnel with expertise in TB diagnostics, clinical trials, and international studies. The CDRC is affiliated with four established clinical study sites in TB endemic countries. At these sites, the CDRC will conduct feasibility studies of new diagnostics and provide input back to the technology holder with respect to further development or evaluation. The CDRC will collaborate with other TB research networks and consortia having a common goal of identifying better diagnostic tools and strategies for TB. The Principal Investigator of the CDRC is Dr. Jerrold J. Ellner and the Co-Principal Investigator and Director of Clinical Studies is Dr. Susan Dorman. The unique mission of the CDRC is to provide data early in the developmental pipeline on the performance of investigational diagnostics and their potential impact on TB management algorithms in endemic countries. The CDRC will contribute to the science of diagnostics and will inform and advise scientists and manufacturers on further development and refinement of diagnostics that promise to accelerate and improve the accuracy of TB diagnosis and the rapid detection of drug resistance. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 26 - 50 |
| Number of part-time staff who are directly involved with TB: | 26 - 50 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | World TB Day |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Research related to TB Diagnostics. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Brazil Republic of Korea South Africa Uganda United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
New Diagnostics: TB CDRC evaluates promising diagnostics in endemic country settings, among clinics and laboratories experienced in the conduct of clinical evaluation. Research: TB CDRC works with partners at cost-effectiveness and comparative-effectiveness research of TB diagnostics and algorithms for TB diagnosis. |
|
Declaration | |
| Declaration of interests: No potential conflicts of interest. | |
| Application date: | July 20, 2010 |
| Last updated: | May 22, 2012 |